Ygiene(TM) Hospital Grade antimicrobial sets the new global standard to
eradicate (100% kill) in seconds the most difficult and lethal microorganisms commonly found in health care facilities, including MRSA and
NEWARK, N.J., Aug. 19 /PRNewswire/ -- BioNeutral announces successful testing of its Ygiene(TM) Hospital Grade antimicrobial against antibiotic-resistant microorganisms and spore forms of microorganisms which represent the major source of hospital acquired infections. In the US, Methicillan Resistant Staphylococcus Aureus (MRSA), Vancomycin-resistant Enterococci, Pan-resistant Klebsiellia pneumoniae and Clostridium difficile are but a few of the various lethal microorganisms present in hospital environments which contribute to over two-and-a-half million hospital acquired infections and one-hundred-thousand deaths annually. Using Ygiene(TM) Hospital Grade antimicrobial to routinely disinfect all areas in health care facilities can save many lives and billions of dollars annually in this global problem. Ygiene(TM) Hospital Grade antimicrobial has been found to completely eradicate these harmful microorganisms in seconds, and is still safe for the environment.
Dr. Philip Tierno, Principal Investigator and Head of Microbiology and Immunology at the Langone NYU Medical Center, has stated regarding Ygiene(TM) Hospital Grade antimicrobial: "No chemical formulation I have ever tested gives a quicker and more complete kill, has a broader spectrum of activity and is more 'green.'"
Dr. Andy Kielbania, Chief Scientist at BioNeutral, stated, "Despite the use of Lysol(R), Clorox(R) bleach, Oxivir(TM)Tb, Medica DC Germicidal Solution, Asepticare(R) TB+II, Germ Control 24 by Pure Biosciences and many other commercial disinfectants, the epidemic of infections continues in health care facilities. Most of these products are not sporicidal and either have no effect on the more difficult organisms, work too slowly or have other draw backs which limit their usefulness to protect and prevent powerful microorganisms from proliferating in health care facilities. This regretfully places patients, staff and visitors at severely added risk."
Stephen J. Browand, Managing Director, said, "It would seem to me that when available, a 'green' antimicrobial, such as our Hospital Grade Disinfectant, which has been proven to be 100% effective against all microorganisms, even spores, 100% of the time, there would be no question about the product my cleaning staff should be using. Saving thousands of lives and millions of dollars would make every health care manager a real life hero. When a scientist with the impeccable credentials and life experience of Dr. Philip Tierno confirms to me what our scientific team has discovered, I get very passionate about its various lifesaving applications. Companies and those concerned individuals serving the health care industry are welcome to contact me and/or our chief scientist personally at BioNeutral to request a copy of the Ygiene(TM) test results and a comparison of other products and brand performance."
About BioNeutral Laboratories Corporation
BioNeutral was organized in 2003 to commercialize a novel combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. The Ygiene(TM) and Ogiene(TM) formulations are "green" and include natural and common ingredients which are found in baby products and the foods we eat. These widely used compounds are combined in unique ways to create enhanced results.
BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. The products include BioNeutralizers and ChemoNeutralizers. BioNeutralizers disinfect, decontaminate and sterilize. BioNeutral believes it has the broadest-based, fastest acting, most effective and safest antimicrobial known. This class of products has important applications for consumers, health care and the military. ChemoNeutralizers irreversibly bind chemical contaminant and toxin molecules and render them harmless. Product applications include industrial pollution and protection against chemical weapons of mass destruction.
Visit http://www.bioneutrallabs.com to view the interview with Dr. Philip Tierno.
About Dr. Philip Tierno
Dr. Tierno is a consultant to BioNeutral. He is the Director of
Clinical Microbiology and Diagnostic Immunology at Langone NYU Medical
Center. He is also an Associate Professor at the New York University School
of Medicine, NYU College of Dentistry and SUNY School of Optometry in New
York City. Dr. Tierno is a member of the NYC Mayor's MRC (Medical Reserve
Corps) and a former member of New York City's task force on bioterrorism.
Dr. Tierno's work in the field of microbiology has resulted in numerous
articles and texts that have been published in medical and scientific
journals. He is co-editor and author of several books on microbes and
BioNeutral Laboratories Corporation USA
Dr. Andy Kielbania
Stephen J. Browand
Dr. Philip Tierno
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
|SOURCE BioNeutral Laboratories Corporation|
Copyright©2008 PR Newswire.
All rights reserved